Summary:
We are seeking adult participants, 60 years of age or older for a Respiratory Syncytial Virus (RSV) vaccine clinical research trial.
This study is evaluating the immune response of an investigational RSV vaccine co-administered with a Pneumococcal Conjugate Vaccine.
Qualified Participants Must:
• 60 years of age or older
•
Additional qualification criteria exist
Qualified Participants May Receive:
- Reimbursement available up to $100 per visit & $51 for travel to on-site visits only
- You are provided study-related care and study vaccine at no cost (no health insurance required)
- You may help make a difference for yourself and for individuals like you